Efficacy of risperidone in the management of suicidality in major depressive disorder.
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2012
At a glance
- Drugs Risperidone (Primary)
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- 21 Feb 2012 Primary outcome amended as reported by ClinicalTrials.gov.
- 21 Feb 2012 Actual patient number changed from 24 to 30 as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History